News
-
-
-
COMMUNIQUÉ DE PRESSE
MindMaze Therapeutics Enrolls First Patients in SwissNeuroRehab Study, Advancing At-Home Reimbursement Strategy in Europe
MindMaze Therapeutics enrolls first patients in SwissNeuroRehab study to advance at-home reimbursement strategy in Europe, aiming to extend patient access from inpatient care to home-based rehabilitation -
-
-
-
-
-
-